1. Home
  2. ESLAW

ESLAW

Estrella Immunopharma Inc. Warrant

Logo Estrella Immunopharma Inc. Warrant

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 03-13-2024 2:06pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Founded: N/A Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: N/A IPO Year: 2021
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: